INVO Fertility (IVF) Q3 Revenue Rises 22% to Approximately $2.2M
Q3 2026 revenue rose to approximately $2.2M from approximately $1.8M a year earlier. Net loss narrowed to approximately $2.1M from approximately $3.4M; Clinic-Level Adjusted EBITDA was $292,114 versus $243,120.Material DetailsContext by AI AnalystThis is an early-stage clinic-network growth story…